Acuvue Oasys for Astigmatism expands parameters

Article

Johnson & Johnson Vision Care, Inc. announced that effective April 15, 2014, Acuvue Oasys for Astigmatism will be available in more parameters.

Jacksonville, FL-Johnson & Johnson Vision Care, Inc. announced that effective April 15, 2014, Acuvue Oasys for Astigmatism will be available in more parameters.

Parameters are being expanded to include -6.00 D to +6.00 D in 0.25 D steps and from -6.50 D to -9.00 D in 0.50 D steps.

With the introduction of these new parameters, the company also announced that effective March 31, 2014, diagnostic lenses for Acuvue Advance for Astigmatism will no longer be available from Johnson & Johnson Vision Care, Inc.   

“In a clinical trial with Acuvue Advance for Astigmatism contact lens wearers, virtually 100% of patients had a prescription match and 100% of patients had first fit success with Acuvue Oasys for Astigmatism,” says W. Lee Ball, OD, FAAO, associate director, professional affairs, Johnson & Johnson Vision Care, Inc.  

Recent Videos
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
© 2024 MJH Life Sciences

All rights reserved.